Cargando…

Perspective: repurposed drugs for COVID-19

INTRODUCTION: The article aims to emphasize the necessity of proper research design, both scientifically and ethically, in order to provide good evidence for physicians to base their decisions on when prescribing drug treatment. METHODS: Research articles and guidelines related to therapy of COVID-1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Na-Bangchang, Kesara, Porasuphatana, Supatra, Karbwang, Juntra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2022
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479713/ https://www.ncbi.nlm.nih.gov/pubmed/36160358 http://dx.doi.org/10.5114/aoms/152467

Ejemplares similares

Traditional Herbal Medicine for the Control of Tropical Diseases
por: Na-Bangchang, Kesara, et al.
Publicado: (2014)

Research and Development of Atractylodes lancea (Thunb) DC. as a Promising Candidate for Cholangiocarcinoma Chemotherapeutics
por: Na-Bangchang, Kesara, et al.
Publicado: (2017)

Preclinical studies of toxicity and anti-cholangiocarcinoma activity of the standardized capsule formulation of Atractylodes lancea (Thunb.) DC
por: Plengsuriyakarn, Tullayakorn, et al.
Publicado: (2023)

Identification of resistance of Plasmodium falciparum to artesunate-mefloquine combination in an area along the Thai-Myanmar border: integration of clinico-parasitological response, systemic drug exposure, and in vitro parasite sensitivity
por: Na-Bangchang, Kesara, et al.
Publicado: (2013)

Pharmacokinetics and pharmacodynamics of fosmidomycin monotherapy and combination therapy with clindamycin in the treatment of multidrug resistant falciparum malaria
por: Na-Bangchang, Kesara, et al.
Publicado: (2007)

Herbal Medicine Development: Methodologies, Challenges, and Issues
por: Karbwang, Juntra, et al.
Publicado: (2019)

Antimalarial activity of plumbagin in vitro and in animal models
por: Sumsakul, Wiriyaporn, et al.
Publicado: (2014)

Physiologically based pharmacokinetic modeling for dose optimization of quinine–phenobarbital coadministration in patients with cerebral malaria
por: Sae‐heng, Teerachat, et al.
Publicado: (2021)

Improved participants’ understanding in a healthy volunteer study using the SIDCER informed consent form: a randomized-controlled study
por: Koonrungsesomboon, Nut, et al.
Publicado: (2015)

β-Eudesmol induces the expression of apoptosis pathway proteins in cholangiocarcinoma cell lines
por: Narahara, Chisato, et al.
Publicado: (2020)

Exploratory, Phase II Controlled Trial of Shiunko Ointment Local Application Twice a Day for 4 Weeks in Ethiopian Patients with Localized Cutaneous Leishmaniasis
por: Na-Bangchang, Kesara, et al.
Publicado: (2016)

Phase I clinical trial to evaluate the safety and pharmacokinetics of capsule formulation of the standardized extract of Atractylodes lancea
por: Na-Bangchang, Kesara, et al.
Publicado: (2021)

Gender-specific distribution of mefloquine in the blood following the administration of therapeutic doses
por: Wernsdorfer, Walther H, et al.
Publicado: (2013)

Toxicity evaluation of cordycepin and its delivery system for sustained in vitro anti-lung cancer activity
por: Aramwit, Pornanong, et al.
Publicado: (2015)

Metabolite Profiling in Anticancer Drug Development: A Systematic Review
por: Muhamad, Nadda, et al.
Publicado: (2020)

Simulation of optimal dose regimens of photoactivated curcumin for antimicrobial resistance pneumonia in COVID-19 patients: A modeling approach
por: Saeheng, Teerachat, et al.
Publicado: (2023)

Pharmacokinetic studies of nanoparticles as a delivery system for conventional drugs and herb-derived compounds for cancer therapy: a systematic review
por: Abdifetah, Omar, et al.
Publicado: (2019)

Modulatory Effects of Atractylodin and β-Eudesmol on Human Cytochrome P450 Enzymes: Potential Drug-Drug Interactions
por: Thiengsusuk, Artitaya, et al.
Publicado: (2023)

Improved parental understanding by an enhanced informed consent form: a randomized controlled study nested in a paediatric drug trial
por: Koonrungsesomboon, Nut, et al.
Publicado: (2019)

The roles of CYP2C19 and CYP3A4 in the in vitro metabolism of β‐eudesmol in human liver: Reaction phenotyping and enzyme kinetics
por: Muhamad, Nadda, et al.
Publicado: (2023)

Chloroquine for Covid 19: introducing drug repurposing to medical students
por: Koren, Gideon, et al.
Publicado: (2020)

Application of active targeting nanoparticle delivery system for chemotherapeutic drugs and traditional/herbal medicines in cancer therapy: a systematic review
por: Muhamad, Nadda, et al.
Publicado: (2018)

Understanding of Essential Elements Required in Informed Consent Form among Researchers and Institutional Review Board Members
por: Koonrungsesomboon, Nut, et al.
Publicado: (2015)

Clinical pharmacokinetics of quinine and its relationship with treatment outcomes in children, pregnant women, and elderly patients, with uncomplicated and complicated malaria: a systematic review
por: Saeheng, Teerachat, et al.
Publicado: (2022)

In vitro antimalarial drug susceptibility in Thai border areas from 1998–2003
por: Chaijaroenkul, Wanna, et al.
Publicado: (2005)

Prediction of improved antimalarial chemotherapy of artesunate-mefloquine in combination with mefloquine sensitive and resistant Plasmodium falciparum malaria
por: Saeheng, Teerachat, et al.
Publicado: (2023)

Computational-based drug repurposing methods in COVID-19
por: Masoudi-Sobhanzadeh, Yosef
Publicado: (2020)

Monitoring antimalarial drug-resistance markers in Somalia
por: Jalei, Abdifatah Abdullahi, et al.
Publicado: (2023)

Repurposing existing drugs for COVID-19: an endocrinology perspective
por: Cadegiani, Flavio A.
Publicado: (2020)

The Effect of ABO Blood Groups, Hemoglobinopathy, and Heme Oxygenase-1 Polymorphisms on Malaria Susceptibility and Severity
por: Kuesap, Jiraporn, et al.
Publicado: (2018)

Declining in efficacy of a three-day combination regimen of mefloquine-artesunate in a multi-drug resistance area along the Thai-Myanmar border
por: Na-Bangchang, Kesara, et al.
Publicado: (2010)

Atractylodes lancea for cholangiocarcinoma: Modulatory effects on CYP1A2 and CYP3A1 and pharmacokinetics in rats and biodistribution in mice
por: Muhamad, Nadda, et al.
Publicado: (2022)

β-Eudesmol Inhibits the Migration of Cholangiocarcinoma Cells by Suppressing Epithelial-Mesenchymal Transition via PI3K/AKT and p38MAPK Modulation
por: Acharya, Bishwanath, et al.
Publicado: (2022)

Pharmacokinetics, toxicity, and cytochrome P450 modulatory activity of plumbagin
por: Sumsakul, Wiriyaporn, et al.
Publicado: (2016)

Effect of β-Eudesmol on NQO1 suppression-enhanced sensitivity of cholangiocarcinoma cells to chemotherapeutic agents
por: Srijiwangsa, Pimradasiri, et al.
Publicado: (2018)

Anticholangiocarcinoma activity and toxicity of the Kaempferia galanga Linn. Rhizome ethanolic extract
por: Amuamuta, Asmare, et al.
Publicado: (2017)

Anticancer Activity of Fucoidan via Apoptosis and Cell Cycle Arrest on Cholangiocarcinoma Cell
por: Chantree, Pathanin, et al.
Publicado: (2021)

Atractylodin and β-eudesmol from Atractylodes lancea (Thunb.) DC. Inhibit Cholangiocarcinoma Cell Proliferation by Downregulating the Notch Signaling Pathway
por: Vanaroj, Peeranate, et al.
Publicado: (2023)

Drug repurposing for COVID-19: a potential threat of self-medication and controlling measures
por: Mallhi, Tauqeer Hussain, et al.
Publicado: (2020)

Population pharmacokinetics of mefloquine given as a 3-day artesunate–mefloquine in patients with acute uncomplicated Plasmodium falciparum malaria in a multidrug-resistant area along the Thai–Myanmar border
por: Hoglund, Richard M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_i125umnell1c6k5h7spklor4po